Megan Anderson Brooks, Vice President, joined CRD Associates in the fall of 2014. Her practice includes:
· Patient advocacy organizations
· Scientific professional associations
· Academic institutions
· Biotechnology companies
Megan has deep expertise in science and health advocacy strategies in support of an innovative and robust biomedical research system. Megan focuses on science and regulatory policy related to basic and clinical scientific research, personalized medicine, federal oversight of diagnostics and biotech devices, and patient-specific issues related to access and patient-centered treatment development. On behalf of clients, she assists in the development and implementation of policy strategies; coordinates congressional briefings and public policy symposiums; organizes client advocacy days on Capitol Hill; and engages in direct lobbying.
As a researcher in the field of neuroscience for over 10 years, Megan brings first-hand experience and a deep scientific understanding to her work on behalf of clients. She conducted research on brain health and the neural mechanisms of learning and memory, and is best known for her work to understand the role of learning in the formation of new neurons in the adult brain. Because of her unique ability to translate complex scientific information into laymen’s terms, Megan has been sought out to speak to scientific groups about effectively communicating with Congress.
Megan previously worked for the Society for Neuroscience developing grassroots advocacy activities and on issues related to research replicability. During a fellowship placement at the New Jersey Department of Health, she assisted in the development of a successful CDC-awarded program that aimed to promote healthy behaviors, increase electronic health record adoption, and develop community-clinical linkages to prevent and control chronic disease in the State. Megan holds a PhD in neuroscience from Rutgers University and was awarded a fellowship from the prestigious Eagleton Institute of Politics.